|
End-of-day quote
Shenzhen S.E.
2026-09-24
|
5-day change | 1st Jan Change | ||
| 10.85 CNY | -1.90% |
|
-1.00% | -10.70% |
| 08-20 | Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 05-22 | Zhuhai Rundu Pharmaceutical Wins China Approval for Pain Relief Drug | MT |
| Market Cap | 3.63B 542M 477M 450M 410M 768M 51.93B 772M 5.38B 2.08B 26.57B 2.03B 1.99B 85.2B | P/E 2024 |
79.5x | P/E 2025 | -63.9x |
|---|---|---|---|---|---|
| Enterprise Value | 3.91B 583M 513M 484M 441M 826M 55.87B 830M 5.79B 2.24B 28.59B 2.19B 2.14B 91.67B | EV / Sales 2024 |
2.95x | EV / Sales 2025 | 3.69x |
| Free-Float |
40.63% | Yield 2024 |
1.57% | Yield 2025 | - |
| 1 day | -1.90% | ||
| 1 week | -1.00% | ||
| Current month | -2.08% | ||
| 1 month | -0.28% | ||
| 3 months | +9.26% | ||
| 6 months | -26.89% | ||
| Current year | -10.70% |
| 1 week | 10.81 | 11.42 | |
| 1 month | 10.53 | 11.42 | |
| Current year | 9.02 | 18.96 | |
| 1 year | 9.02 | 18.96 | |
| 3 years | 6.81 | 19.56 | |
| 5 years | 6.81 | 22.25 | |
| 10 years | 6.81 | 22.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Liu
CEO | Chief Executive Officer | 50 | 2018-10-20 |
Shen Hua Shi
DFI | Director of Finance/CFO | 63 | 2011-04-15 |
Chun Yan You
PRN | Corporate Officer/Principal | 50 | 2018-01-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Xin Min Chen
CHM | Chairman | 60 | 2018-10-20 |
Zhi Jun Hua
CHM | Chairman | 57 | 2011-04-15 |
Jie Liu
BRD | Director/Board Member | 50 | 2020-03-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.90% | -1.00% | -16.15% | -16.41% | 541M | ||
| +0.13% | +2.69% | +59.53% | +114.96% | 1,053B | ||
| +0.20% | +0.37% | +53.50% | +68.98% | 652B | ||
| -0.29% | +0.12% | +20.16% | +73.07% | 468B | ||
| -0.85% | -0.25% | +38.63% | +44.47% | 351B | ||
| +0.71% | +3.26% | +22.46% | +30.30% | 273B | ||
| +1.23% | +1.00% | +11.97% | +13.63% | 254B | ||
| +2.11% | +9.17% | +48.49% | +54.88% | 220B | ||
| +0.83% | +0.03% | +32.78% | +101.21% | 186B | ||
| 0.00% | -9.43% | -31.91% | -60.56% | 170B | ||
| Average | +0.22% | +0.21% | +23.95% | +42.45% | 362.79B | |
| Weighted average by Cap. | +0.26% | +1.00% | +38.88% | +68.41% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.18B 176M 155M 146M 133M 250M 16.9B 251M 1.75B 678M 8.65B 662M 648M 27.72B | 1.18B 175M 154M 146M 133M 249M 16.81B 250M 1.74B 674M 8.6B 659M 645M 27.58B |
| Net income | 39.88M 5.95M 5.23M 4.93M 4.5M 8.43M 570M 8.47M 59.1M 22.85M 292M 22.34M 21.85M 935M | -63.47M -9.47M -8.33M -7.85M -7.16M -13.41M -907M -13.48M -94.05M -36.37M -464M -35.55M -34.78M -1.49B |
| Net Debt | 294M 43.85M 38.56M 36.37M 33.17M 62.11M 4.2B 62.44M 436M 168M 2.15B 165M 161M 6.89B | 276M 41.19M 36.22M 34.16M 31.15M 58.34M 3.95B 58.64M 409M 158M 2.02B 155M 151M 6.47B |
Employees
1,655
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-24 | CN¥10.85 | -1.90% | 4,578,638 |
| 26-09-23 | CN¥11.06 | -1.60% | 4,881,500 |
| 26-09-22 | CN¥11.24 | -1.14% | 6,516,300 |
| 26-09-21 | CN¥11.37 | +4.12% | 8,368,740 |
| 26-09-18 | CN¥10.92 | -0.36% | 5,557,822 |
- Stock Market
- Stocks
- 002923 Stock
Select your edition
All financial news and data tailored to specific country editions
















